+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Digital Therapeutics - Global Market Trajectory & Analytics

  • ID: 4804793
  • Report
  • May 2021
  • Region: Global
  • 205 pages
  • Global Industry Analysts, Inc

FEATURED COMPANIES

  • Canary Health, Inc.
  • Dthera Sciences
  • Fitbit Health Solutions
  • Livongo Health, Inc.
  • Medtronic, Plc
  • Omada Health, Inc.
  • MORE

Global Digital Therapeutics Market to Reach US$1.6 Billion by the Year 2027

Amid the COVID-19 crisis, the global market for Digital Therapeutics estimated at US$347.2 Million in the year 2020, is projected to reach a revised size of US$1.6 Billion by 2027, growing at a CAGR of 24.6% over the period 2020-2027.Preventive, one of the segments analyzed in the report, is projected to grow at a 22.7% CAGR to reach US$421.2 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Treatment/Care segment is readjusted to a revised 25.3% CAGR for the next 7-year period. This segment currently accounts for a 71% share of the global Digital Therapeutics market.

The U.S. Accounts for Over 29.9% of the Global Market Size in 2020, While China is Forecast to Grow at a 24.1% CAGR for the Period of 2020-2027

The Digital Therapeutics market in the U.S. is estimated at US$103.8 Million in the year 2020. The country currently accounts for a 29.9% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$282.8 Million in the year 2027 trailing a CAGR of 24.1% through 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 21.6% and 21.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 17.5% CAGR while Rest of European market (as defined in the study) will reach US$282.8 Million by the year 2027.

Select Competitors (Total 56 Featured) -

  • Canary Health, Inc.
  • Dthera Sciences
  • Fitbit Health Solutions
  • Livongo Health, Inc.
  • Medtronic, Plc
  • Omada Health, Inc.
  • Propeller Health
  • Pear Therapeutics, Inc.
  • Proteus Digital Health, Inc.
  • WellDoc, Inc.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Canary Health, Inc.
  • Dthera Sciences
  • Fitbit Health Solutions
  • Livongo Health, Inc.
  • Medtronic, Plc
  • Omada Health, Inc.
  • MORE

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • Influencer Market Insights
  • Impact of Covid-19 and a Looming Global Recession
  • Digital Therapeutics: An Introduction
  • Outlook
  • Leading Markets
  • Factors Impeding Growth
  • Canary Health, Inc. (USA)
  • Dthera Sciences (USA)
  • Fitbit Health Solutions (USA
  • Livongo Health, Inc. (USA)
  • Medtronic, Plc (Ireland)
  • Omada Health, Inc. (USA)
  • Propeller Health (USA)
  • Pear Therapeutics, Inc. (USA)
  • Proteus Digital Health, Inc. (USA)
  • WellDoc, Inc. (USA)
  • Digital Therapeutics Continue to Attract Venture Capital Investments
  • Exhibit 1: Total Venture Capital Funding and Number of Deals in Digital Health Space: 2011-2018
  • Exhibit 2: Digital Health Funding by Segment (in US$ Million): 9M 2019
  • Startups Flock the Digital Therapeutics Market
  • Select Digital Therapeutics Startups
  • Digital Health Unicorn Startups
  • Exhibit 3: Quarterly Investments by Digital Therapeutics Startups in US$ Million: Q1 2018 to Q2 2019
  • Pipeline Products Drive Growth Prospects
  • A Snapshot of Select DTx Pipeline Products
  • Pharma Majors Foray into Uncharted Territory
  • Pharmaceutical Companies Team Up with Payers to Seek Reimbursement
  • Growing Focus on Preventative Healthcare Widens Growth Opportunities
  • Overcoming the Stigma of Mental Health through Digital Therapeutics
  • Global Number of People Suffering from Mental Disorders (In Million)
  • Growing Prevalence of Chronic Diseases to Boost Market Growth
  • Exhibit 4: Worldwide Prevalence of Diabetes: Number of Adults (20-79) with Diabetes (in Millions) by Region for 2017 and 2045
  • Exhibit 5: Global Annual Medical Cost of CVD in US$ Billion (2010-2030)
  • Global Obesity Epidemic: Percentage of Overweight, Obese, and Severely Obese Adults for 2014 & 2025
  • Digital Therapeutics in Oncology
  • Proliferation of Smart Devices Bodes Well for Market Growth
  • Exhibit 6: Smartphone Penetration (as a Proportion of Total Mobile Users) by Region for the Years 2018 and 2025
  • Exhibit 7: United States Mobile Health Apps Market by Type (in %): 2018 & 2025
  • Growing Focus on Reducing Healthcare Costs Bolsters Market Growth
  • Exhibit 8: Global Healthcare Expenditure (In US$ Trillion) for the Years 2017, 2019, and 2022
  • Aging Population and their Vulnerability to Various Health Conditions: A Vital Growth Driver
  • Exhibit 9: Global Population for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
  • Table 1: World Current & Future Analysis for Digital Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 2: World 7-Year Perspective for Digital Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2020 & 2027
  • Table 3: World Current & Future Analysis for Preventive by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 4: World 7-Year Perspective for Preventive by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 5: World Current & Future Analysis for Treatment/Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 6: World 7-Year Perspective for Treatment/Care by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 7: World Current & Future Analysis for B2C by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 8: World 7-Year Perspective for B2C by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 9: World Current & Future Analysis for B2B by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 10: World 7-Year Perspective for B2B by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027

III. MARKET ANALYSIS

  • Table 11: USA Current & Future Analysis for Digital Therapeutics by Application - Preventive and Treatment/Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 12: USA 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Sales for Preventive and Treatment/Care for the Years 2020 & 2027
  • Table 13: USA Current & Future Analysis for Digital Therapeutics by Sales Channel - B2C and B2B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 14: USA 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Sales for B2C and B2B for the Years 2020 & 2027
  • Table 15: Canada Current & Future Analysis for Digital Therapeutics by Application - Preventive and Treatment/Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 16: Canada 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Sales for Preventive and Treatment/Care for the Years 2020 & 2027
  • Table 17: Canada Current & Future Analysis for Digital Therapeutics by Sales Channel - B2C and B2B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 18: Canada 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Sales for B2C and B2B for the Years 2020 & 2027
  • Table 19: Japan Current & Future Analysis for Digital Therapeutics by Application - Preventive and Treatment/Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 20: Japan 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Sales for Preventive and Treatment/Care for the Years 2020 & 2027
  • Table 21: Japan Current & Future Analysis for Digital Therapeutics by Sales Channel - B2C and B2B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 22: Japan 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Sales for B2C and B2B for the Years 2020 & 2027
  • Table 23: China Current & Future Analysis for Digital Therapeutics by Application - Preventive and Treatment/Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 24: China 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Sales for Preventive and Treatment/Care for the Years 2020 & 2027
  • Table 25: China Current & Future Analysis for Digital Therapeutics by Sales Channel - B2C and B2B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 26: China 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Sales for B2C and B2B for the Years 2020 & 2027
  • Table 27: Europe Current & Future Analysis for Digital Therapeutics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 28: Europe 7-Year Perspective for Digital Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2020 & 2027
  • Table 29: Europe Current & Future Analysis for Digital Therapeutics by Application - Preventive and Treatment/Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 30: Europe 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Sales for Preventive and Treatment/Care for the Years 2020 & 2027
  • Table 31: Europe Current & Future Analysis for Digital Therapeutics by Sales Channel - B2C and B2B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 32: Europe 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Sales for B2C and B2B for the Years 2020 & 2027
  • Table 33: France Current & Future Analysis for Digital Therapeutics by Application - Preventive and Treatment/Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 34: France 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Sales for Preventive and Treatment/Care for the Years 2020 & 2027
  • Table 35: France Current & Future Analysis for Digital Therapeutics by Sales Channel - B2C and B2B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 36: France 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Sales for B2C and B2B for the Years 2020 & 2027
  • Table 37: Germany Current & Future Analysis for Digital Therapeutics by Application - Preventive and Treatment/Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 38: Germany 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Sales for Preventive and Treatment/Care for the Years 2020 & 2027
  • Table 39: Germany Current & Future Analysis for Digital Therapeutics by Sales Channel - B2C and B2B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 40: Germany 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Sales for B2C and B2B for the Years 2020 & 2027
  • Table 41: Italy Current & Future Analysis for Digital Therapeutics by Application - Preventive and Treatment/Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 42: Italy 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Sales for Preventive and Treatment/Care for the Years 2020 & 2027
  • Table 43: Italy Current & Future Analysis for Digital Therapeutics by Sales Channel - B2C and B2B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 44: Italy 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Sales for B2C and B2B for the Years 2020 & 2027
  • Table 45: UK Current & Future Analysis for Digital Therapeutics by Application - Preventive and Treatment/Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 46: UK 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Sales for Preventive and Treatment/Care for the Years 2020 & 2027
  • Table 47: UK Current & Future Analysis for Digital Therapeutics by Sales Channel - B2C and B2B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 48: UK 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Sales for B2C and B2B for the Years 2020 & 2027
  • Table 49: Rest of Europe Current & Future Analysis for Digital Therapeutics by Application - Preventive and Treatment/Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 50: Rest of Europe 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Sales for Preventive and Treatment/Care for the Years 2020 & 2027
  • Table 51: Rest of Europe Current & Future Analysis for Digital Therapeutics by Sales Channel - B2C and B2B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 52: Rest of Europe 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Sales for B2C and B2B for the Years 2020 & 2027
  • Table 53: Asia-Pacific Current & Future Analysis for Digital Therapeutics by Application - Preventive and Treatment/Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 54: Asia-Pacific 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Sales for Preventive and Treatment/Care for the Years 2020 & 2027
  • Table 55: Asia-Pacific Current & Future Analysis for Digital Therapeutics by Sales Channel - B2C and B2B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 56: Asia-Pacific 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Sales for B2C and B2B for the Years 2020 & 2027
  • Table 57: Rest of World Current & Future Analysis for Digital Therapeutics by Application - Preventive and Treatment/Care - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 58: Rest of World 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Sales for Preventive and Treatment/Care for the Years 2020 & 2027
  • Table 59: Rest of World Current & Future Analysis for Digital Therapeutics by Sales Channel - B2C and B2B - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 60: Rest of World 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Sales for B2C and B2B for the Years 2020 & 2027

IV. COMPETITION

  • Total Companies Profiled: 56
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Canary Health, Inc.
  • Dthera Sciences
  • Fitbit Health Solutions
  • Livongo Health, Inc.
  • Medtronic, Plc
  • Omada Health, Inc.
  • Propeller Health
  • Pear Therapeutics, Inc.
  • Proteus Digital Health, Inc.
  • WellDoc, Inc.
Note: Product cover images may vary from those shown
Adroll
adroll